Navigation Links
Porter Novelli Named Agency of Record for Prix Galien USA Awards
Date:6/29/2011

NEW YORK, June 29, 2011 /PRNewswire/ -- Global public relations leader Porter Novelli today announced that it has been named agency of record for the Prix Galien USA Awards, which recognize excellence in biopharmaceutical research and development that has significantly improved the human condition. Porter Novelli will be responsible for raising awareness of the award in the U.S. and driving volume of submissions.

The Prix Galien is internationally renowned for recognizing the development of innovative medicines and medical technologies. Judged by a prestigious committee of scientists and clinicians, the Prix Galien is considered the industry's highest accolade. The awards are presented in the following categories, in which one to three prizes are given: Best Pharmaceutical Agent, Best Biotechnical Product and Best Medical Device.

"Innovation in medicine is something that needs to be nurtured, acknowledged and rewarded," said Susan Hayes, global director, health, Porter Novelli. "Porter Novelli is pleased to support the Prix Galien's commitment to progress in health and medicine, a goal that everyone in the health care community shares."

The Prix Galien USA award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. The 2011 Prix Galien USA Awards will be held on September 27, 2011 at the American Museum of Natural History in New York City.

As part of the events that take place around the awards, Peter Pitts, director of global regulatory and health policy at Porter Novelli, will participate in the panel discussion, "What is 'Value' and How Can it be Measured and Demonstrated in Therapeutic Innovations? Breaking Down the Barriers of the Past."

About Porter Novelli

A global public relations leader, Porter Novelli was founded in 1972 and is a part of Omnicom Group Inc. (NYSE: OMC). In 90 offices in nearly 60 countries, Porter Novelli combines the power of immersion with the rigor of research to create deep human insights that enable the agency to transform the opinions, beliefs and behaviors of those who matter most to its clients. For additional information, please visit www.porternovelli.com.

Contact:
Catherine Sullivan
Catherine.Sullivan@porternovelli.com
212-601-8315


'/>"/>
SOURCE Porter Novelli
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
2. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
3. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
4. Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium
5. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
6. Bend Research Named Large Distinguished Business of the Year by Bend Chamber of Commerce Membership
7. Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner
8. Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®
9. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
10. Robert Kline, President & CEO, Medivance Named Ernst & Young Entrepreneur Of The Year® 2011 Regional Award Winner
11. AlphaDetail, Healthcare Market Research Specialist, Named to the Honomichl Top 50
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):